Login / Signup

Importance of quality of life in early phase clinical trials: A case study of selinexor in multiple myeloma.

Rajshekhar ChakrabortyFabio Efficace
Published in: British journal of haematology (2020)
Keyphrases
  • multiple myeloma
  • clinical trial
  • phase ii
  • open label
  • double blind
  • study protocol
  • phase iii